{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:13:46Z","timestamp":1784762026836,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,3,28]],"date-time":"2010-03-28T00:00:00Z","timestamp":1269734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00011-010-0179-3","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T23:24:00Z","timestamp":1269645840000},"page":"667-678","source":"Crossref","is-referenced-by-count":19,"title":["Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam"],"prefix":"10.1007","volume":"59","author":[{"given":"Javeria Ali","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Yashpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,28]]},"reference":[{"issue":"2 Suppl 1","key":"179_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200422001-00002","volume":"22","author":"TK Kvien","year":"2004","unstructured":"Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004;22(2 Suppl 1):1\u201312.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"179_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0895-4356(00)00204-3","volume":"53","author":"MA Sprangers","year":"2000","unstructured":"Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer JB, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53(9):895\u2013907.","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"179_CR3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","volume":"334","author":"MA Testa","year":"1996","unstructured":"Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835\u201340.","journal-title":"N Engl J Med"},{"issue":"6","key":"179_CR4","first-page":"1241","volume":"34","author":"T Uhlig","year":"2007","unstructured":"Uhlig T, Loge JH, Kristiansen IS, Kvien TK. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007;34(6):1241\u20137.","journal-title":"J Rheumatol"},{"issue":"4","key":"179_CR5","first-page":"733","volume":"22","author":"EM Badley","year":"1995","unstructured":"Badley EM, Webster GK, Rasooly I. The impact of musculoskeletal disorders in the population: are they just aches and pains? Findings from the 1990 Ontario Health Survey. J Rheumatol. 1995;22(4):733\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"179_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00002281-200203000-00008","volume":"14","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol. 2002;14(2):121\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"179_CR7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2002.004861","volume":"62","author":"AM Chorus","year":"2003","unstructured":"Chorus AM, Miedema HS, Boonen A, Van Der LS. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis. 2003;62(12):1178\u201384.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"179_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.NNR.0000299850.29558.db","volume":"56","author":"KH Sousa","year":"2007","unstructured":"Sousa KH, Ryu E, Kwok OM, Cook SW, West SG. Development of a model to measure symptom status in persons living with rheumatoid arthritis. Nurs Res. 2007;56(6):434\u201340.","journal-title":"Nurs Res"},{"key":"179_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ard.2007.084848","volume":"68","author":"U Kalyoncu","year":"2008","unstructured":"Kalyoncu U, Dougados M, Daures JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2008;68:183\u2013190.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"179_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137\u201345.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"179_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/1529-0131(200002)43:2<386::AID-ANR19>3.0.CO;2-Z","volume":"43","author":"T Sokka","year":"2000","unstructured":"Sokka T, Kankainen A, Hannonen P. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis Rheum. 2000;43(2):386\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"179_CR12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/art.1780210714","volume":"21","author":"RF Meenan","year":"1978","unstructured":"Meenan RF, Yelin EH, Henke CJ, Curtis DL, Epstein WV. The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs. Arthritis Rheum. 1978;21(7):827\u201333.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"179_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0049-0172(00)80017-7","volume":"29","author":"KM Pugner","year":"2000","unstructured":"Pugner KM, Scott DI, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum. 2000;29(5):305\u201320.","journal-title":"Semin Arthritis Rheum"},{"key":"179_CR14","first-page":"47","volume":"44","author":"E Yelin","year":"1996","unstructured":"Yelin E. The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates. J Rheumatol Suppl. 1996;44:47\u201351.","journal-title":"J Rheumatol Suppl"},{"issue":"2","key":"179_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P","volume":"42","author":"G Kobelt","year":"1999","unstructured":"Kobelt G, Eberhardt K, Jonsson L, Jonsson B. Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum. 1999;42(2):347\u201356.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"179_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0272989X06297389","volume":"27","author":"B Fautrel","year":"2007","unstructured":"Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, et al. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making. 2007;27(2):138\u201350.","journal-title":"Med Decis Making"},{"issue":"5","key":"179_CR17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/art.23453","volume":"58","author":"M Chen","year":"2008","unstructured":"Chen M, Boilard E, Nigrovic PA, Clark P, Xu D, Fitzgerald GA, et al. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K\/BxN serum-transfer arthritis. Arthritis Rheum. 2008;58(5):1354\u201365.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"179_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/rheumatology\/32.1.31","volume":"32","author":"A Hernanz","year":"1993","unstructured":"Hernanz A, De ME, Romera N, Perez-Ayala C, Gijon J, Arnalich F. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol. 1993;32(1):31\u20135.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"179_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/03009749109096808","volume":"20","author":"J Larsson","year":"1991","unstructured":"Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol. 1991;20(5):326\u201335.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"179_CR20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neuroscience.2008.06.049","volume":"155","author":"S Averill","year":"2008","unstructured":"Averill S, Inglis JJ, King VR, Thompson SW, Cafferty WB, Shortland PJ, et al. Reg-2 expression in dorsal root ganglion neurons after adjuvant-induced monoarthritis. Neuroscience. 2008;155(4):1227\u201336.","journal-title":"Neuroscience"},{"issue":"2","key":"179_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.2001.00175.x","volume":"77","author":"DG Bulling","year":"2001","unstructured":"Bulling DG, Kelly D, Bond S, McQueen DS, Seckl JR. Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia. J Neurochem. 2001;77(2):372\u201382.","journal-title":"J Neurochem"},{"issue":"2","key":"179_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.bjp.0702080","volume":"125","author":"E Dowd","year":"1998","unstructured":"Dowd E, McQueen DS, Chessell IP, Humphrey PP. P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol. 1998;125(2):341\u20136.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"179_CR23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1523\/JNEUROSCI.0882-03.2004","volume":"24","author":"KJ Bar","year":"2004","unstructured":"Bar KJ, Natura G, Telleria-Diaz A, Teschner P, Vogel R, Vasquez E, et al. Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1\u2013EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint. J Neurosci. 2004;24(3):642\u201351.","journal-title":"J Neurosci"},{"issue":"4","key":"179_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00001756-200003200-00017","volume":"11","author":"M Fang","year":"2000","unstructured":"Fang M, Wang Y, Liu HX, Liu XS, Han JS. Decreased GDNF mRNA expression in dorsal spinal cord of unilateral arthritic rat. Neuroreport. 2000;11(4):737\u201341.","journal-title":"Neuroreport"},{"issue":"8","key":"179_CR25","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1460-9568.2005.04382.x","volume":"22","author":"NR Sharif","year":"2005","unstructured":"Sharif NR, Cahill CM, Ribeiro-da-Silva A, Menard HA, Henry JL. Remodelling of spinal nociceptive mechanisms in an animal model of monoarthritis. Eur J Neurosci. 2005;22(8):2005\u201315.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"179_CR26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(00)00503-0","volume":"102","author":"L Djouhri","year":"2001","unstructured":"Djouhri L, Lawson SN. Increased conduction velocity of nociceptive primary afferent neurons during unilateral hindlimb inflammation in the anaesthetised guinea-pig. Neuroscience. 2001;102(3):669\u201379.","journal-title":"Neuroscience"},{"issue":"4","key":"179_CR27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1523\/JNEUROSCI.3388-05.2006","volume":"26","author":"L Djouhri","year":"2006","unstructured":"Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci. 2006;26(4):1281\u201392.","journal-title":"J Neurosci"},{"issue":"2","key":"179_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(96)00604-7","volume":"390","author":"F Beiche","year":"1996","unstructured":"Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 1996;390(2):165\u20139.","journal-title":"FEBS Lett"},{"key":"179_CR29","doi-asserted-by":"crossref","unstructured":"MacDonald TM, Pettitt D, Lee FH, Schwartz JS. Channelling of patients taking NSAIDs or cyclooxygenase-2-specific inhibitors and its effect on interpretation of outcomes. Rheumatology (Oxford) 2003 Nov;42 Suppl 3:iii3\u201310.","DOI":"10.1093\/rheumatology\/keg492"},{"issue":"11","key":"179_CR30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00044011-200828110-00002","volume":"28","author":"K Johnell","year":"2008","unstructured":"Johnell K, Fastbom J. Concomitant use of gastroprotective drugs among elderly NSAID\/COX-2 selective inhibitor users: a nationwide register-based study. Clin Drug Investig. 2008;28(11):687\u201395.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"179_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s000110050174","volume":"46","author":"JM Laird","year":"1997","unstructured":"Laird JM, Herrero JF, Garcia de la RP, Cervero F. Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components. Inflamm Res. 1997;46(6):203\u201310.","journal-title":"Inflamm Res"},{"issue":"2","key":"179_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.intimp.2004.01.009","volume":"4","author":"FF Lam","year":"2004","unstructured":"Lam FF, Wong HH, Ng ES. Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats. Int Immunopharmacol. 2004;4(2):299\u2013310.","journal-title":"Int Immunopharmacol"},{"issue":"1\u20132","key":"179_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10787-006-1512-x","volume":"14","author":"VL Kumar","year":"2006","unstructured":"Kumar VL, Roy S, Sehgal R, Padhy BM. A comparative study on the efficacy of rofecoxib in monoarticular arthritis induced by latex of Calotropis procera and Freund\u2019s complete adjuvant. Inflammopharmacol. 2006;14(1\u20132):17\u201321.","journal-title":"Inflammopharmacol"},{"issue":"1","key":"179_CR34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3959(92)90133-V","volume":"48","author":"SH Butler","year":"1992","unstructured":"Butler SH, Godefroy F, Besson JM, Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain. 1992;48(1):73\u201381.","journal-title":"Pain"},{"issue":"2","key":"179_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0270(99)00004-7","volume":"87","author":"GM Pitcher","year":"1999","unstructured":"Pitcher GM, Ritchie J, Henry JL. Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands. J Neurosci Methods. 1999;87(2):185\u201393.","journal-title":"J Neurosci Methods"},{"key":"179_CR36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0021-9681(63)90136-X","volume":"16","author":"CM Pearson","year":"1963","unstructured":"Pearson CM. Experimental joint disease observations on adjuvant-induced arthritis. J Chronic Dis. 1963;16:863\u201374.","journal-title":"J Chronic Dis"},{"issue":"3","key":"179_CR37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pbb.2007.05.010","volume":"87","author":"H Vermeirsch","year":"2007","unstructured":"Vermeirsch H, Biermans R, Salmon PL, Meert TF. Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat. Pharmacol Biochem Behav. 2007;87(3):349\u201359.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"179_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejpain.2005.08.003","volume":"10","author":"AW Wilson","year":"2006","unstructured":"Wilson AW, Medhurst SJ, Dixon CI, Bontoft NC, Winyard LA, Brackenborough KT, et al. An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models. Eur J Pain. 2006;10(6):537\u201349.","journal-title":"Eur J Pain"},{"issue":"3","key":"179_CR39","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0041-1345(99)00049-4","volume":"31","author":"GW Cannon","year":"1999","unstructured":"Cannon GW, Openshaw S, Clayton F, Sawitzke AD, Griffiths MM. Adjuvant arthritis in rats: susceptibility to arthritis induced by Mycobacterium butyricum and Mycobacterium tuberculosis. Transplant Proc. 1999;31(3):1590\u20131.","journal-title":"Transplant Proc"},{"issue":"1","key":"179_CR40","first-page":"7","volume":"20","author":"GW Cannon","year":"1993","unstructured":"Cannon GW, Woods ML, Clayton F, Griffiths MM. Induction of arthritis in DA rats by incomplete Freund\u2019s adjuvant. J Rheumatol. 1993;20(1):7\u201311.","journal-title":"J Rheumatol"},{"issue":"6","key":"179_CR41","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1529-0131(200106)44:6<1428::AID-ART238>3.0.CO;2-U","volume":"44","author":"AC Issekutz","year":"2001","unstructured":"Issekutz AC, Mu JY, Liu G, Melrose J, Berg EL. E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat. Arthritis Rheum. 2001;44(6):1428\u201337.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"179_CR42","first-page":"633","volume":"14","author":"T Haak","year":"1996","unstructured":"Haak T, Delverdier M, Amardeilh MF, Oswald IP, Toutain PL. Pathologic study of an experimental canine arthritis induced with Complete Freund\u2019s Adjuvant. Clin Exp Rheumatol. 1996;14(6):633\u201341.","journal-title":"Clin Exp Rheumatol"},{"key":"179_CR43","doi-asserted-by":"crossref","unstructured":"Weinblatt ME. Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 2003 Nov;62 Suppl 2:ii94\u2013ii96.","DOI":"10.1136\/ard.62.suppl_2.ii94"},{"key":"179_CR44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1600-065x.2001.1840117.x","volume":"184","author":"R Holmdahl","year":"2001","unstructured":"Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Wester L, Holmberg J, et al. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev. 2001;184:184\u2013202.","journal-title":"Immunol Rev"},{"issue":"1","key":"179_CR45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-4328(87)90032-5","volume":"24","author":"B Calvino","year":"1987","unstructured":"Calvino B, Crepon-Bernard MO, Le BD. Parallel clinical and behavioural studies of adjuvant-induced arthritis in the rat: possible relationship with \u2018chronic pain\u2019. Behav Brain Res. 1987;24(1):11\u201329.","journal-title":"Behav Brain Res"},{"issue":"2","key":"179_CR46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3959(87)90118-7","volume":"28","author":"F Godefroy","year":"1987","unstructured":"Godefroy F, Weil-Fugazza J, Besson JM. Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat. Pain. 1987;28(2):223\u201338.","journal-title":"Pain"},{"issue":"1","key":"179_CR47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-510X(84)90108-4","volume":"63","author":"H Reiber","year":"1984","unstructured":"Reiber H, Suckling AJ, Rumsby MG. The effect of Freund\u2019s adjuvants on blood\u2013cerebrospinal fluid barrier permeability. J Neurol Sci. 1984;63(1):55\u201361.","journal-title":"J Neurol Sci"},{"issue":"3","key":"179_CR48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0304-3959(88)90140-6","volume":"35","author":"MJ Millan","year":"1988","unstructured":"Millan MJ, Czlonkowski A, Morris B, Stein C, Arendt R, Huber A, et al. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain. 1988;35(3):299\u2013312.","journal-title":"Pain"},{"issue":"2","key":"179_CR49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0091-3057(88)90372-3","volume":"31","author":"C Stein","year":"1988","unstructured":"Stein C, Millan MJ, Herz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav. 1988;31(2):445\u201351.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"179_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0165-0270(93)90103-X","volume":"49","author":"LF Donaldson","year":"1993","unstructured":"Donaldson LF, Seckl JR, McQueen DS. A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose. J Neurosci Methods. 1993;49(1\u20132):5\u201310.","journal-title":"J Neurosci Methods"},{"issue":"2","key":"179_CR51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.103.050781","volume":"306","author":"Y Nagakura","year":"2003","unstructured":"Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, et al. Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther. 2003;306(2):490\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"179_CR52","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/art.23063","volume":"56","author":"JJ Inglis","year":"2007","unstructured":"Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007;56(12):4015\u201323.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"179_CR53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1460-9568.2008.06076.x","volume":"27","author":"Y Lu","year":"2008","unstructured":"Lu Y, McNearney TA, Wilson SP, Yeomans DC, Westlund KN. Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis. Eur J Neurosci. 2008;27(5):1153\u201365.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"179_CR54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","volume":"48","author":"PG Conaghan","year":"2003","unstructured":"Conaghan PG, O\u2019Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum. 2003;48(1):64\u201371.","journal-title":"Arthritis Rheum"},{"key":"179_CR55","doi-asserted-by":"crossref","unstructured":"Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002 Nov;61 Suppl 2:ii84\u2013ii86.","DOI":"10.1136\/ard.61.suppl_2.ii84"},{"issue":"4","key":"179_CR56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00270365","volume":"7","author":"JT Halla","year":"1987","unstructured":"Halla JT, Hardin JG, Fallahi S. The nature of the onset of rheumatoid arthritis: a reassessment. Rheumatol Int. 1987;7(4):169\u201371.","journal-title":"Rheumatol Int"},{"issue":"3","key":"179_CR57","first-page":"628","volume":"14","author":"JT Halla","year":"1987","unstructured":"Halla JT, Hirsch V. Monoarthritis as the presenting manifestation of localized Ewing\u2019s sarcoma in an older patient. J Rheumatol. 1987;14(3):628\u201331.","journal-title":"J Rheumatol"},{"issue":"6A","key":"179_CR58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9343(83)90471-0","volume":"75","author":"AT Masi","year":"1983","unstructured":"Masi AT. Articular patterns in the early course of rheumatoid arthritis. Am J Med. 1983;75(6A):16\u201326.","journal-title":"Am J Med"},{"key":"179_CR59","doi-asserted-by":"crossref","unstructured":"Hazes JM. Determinants of physical function in rheumatoid arthritis: association with the disease process. Rheumatology (Oxford) 2003 May;42 Suppl 2:ii17\u2013ii21.","DOI":"10.1093\/rheumatology\/keg328"},{"issue":"10","key":"179_CR60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01757699","volume":"44","author":"G Engelhardt","year":"1995","unstructured":"Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res. 1995;44(10):423\u201333.","journal-title":"Inflamm Res"},{"issue":"3","key":"179_CR61","first-page":"436","volume":"29","author":"DE Furst","year":"2002","unstructured":"Furst DE, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S, et al. Dose response and safety study of meloxicam up to 22.5\u00a0mg daily in rheumatoid arthritis: a 12\u00a0week multicenter, double blind, dose response study versus placebo and diclofenac. J Rheumatol. 2002;29(3):436\u201346.","journal-title":"J Rheumatol"},{"issue":"1","key":"179_CR62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00000542-200207000-00024","volume":"97","author":"K Omote","year":"2002","unstructured":"Omote K, Kawamata T, Nakayama Y, Yamamoto H, Kawamata M, Namiki A. Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model. Anesthesiology. 2002;97(1):170\u20136.","journal-title":"Anesthesiology"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-010-0179-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0179-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T09:49:14Z","timestamp":1558518554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-010-0179-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,28]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s00011-010-0179-3","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,28]]}}}